ArticlePNAS nexus2026
Painful neuromas exhibit axonal phenotypic shift via nociceptive and mechanosensitive marker up-regulation.
Article in PNAS nexus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Neuropathic pain encompasses a spectrum of conditions that significantly impact quality of life. In case of nerve injuries, when regenerating axons fail to reach their target organs, they can form painful neuromas, yet the mechanisms underlying their formation remain unclear. In this exploratory study, we analyzed the neural components of painful neuromas by examining the expression patterns of key nociceptor markers. Neural components within neuromas exhibited up-regulated growth-associated protein 43, indicating their regenerative potential. Calcitonin gene-related peptide was expressed in 84% of axons, versus 3% in healthy nerves, suggesting a phenotypic shift toward a nociceptive profile. We also observed increased expression of the mechanosensitive channel Piezo2 in 78% of axons and up-regulation of the low-threshold sodium channel Nav1.3, consistent with heightened mechanosensitivity and hyperexcitability. These observations identify candidate molecular alterations in painful neuromas and may provide a guide for future development of targeted therapies for neuroma-related pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.